Diagnostics | Free Full-Text | Mechanisms of Resistance to CDK4/6 Inhibitors and Predictive Biomarkers of Response in HR+/HER2-Metastatic Breast Cancer—A Review of the Literature
Continuous treatment with abemaciclib leads to sustained and efficient inhibition of breast cancer cell proliferation : r/science